181 related articles for article (PubMed ID: 6329175)
1. Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.
Zavoico GB; Feinstein MB
Biochem Biophys Res Commun; 1984 Apr; 120(2):579-85. PubMed ID: 6329175
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
Feinstein MB; Egan JJ; Sha'afi RI; White J
Biochem Biophys Res Commun; 1983 Jun; 113(2):598-604. PubMed ID: 6307295
[TBL] [Abstract][Full Text] [Related]
3. Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin.
Feinstein MB; Egan JJ; Opas EE
J Biol Chem; 1983 Jan; 258(2):1260-7. PubMed ID: 6571835
[TBL] [Abstract][Full Text] [Related]
4. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
Cutler LS; Christian CP; Feinstein MB
Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
[TBL] [Abstract][Full Text] [Related]
5. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
6. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
Brass LF; Woolkalis MJ
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):73-80. PubMed ID: 1310010
[TBL] [Abstract][Full Text] [Related]
8. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
9. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452
[TBL] [Abstract][Full Text] [Related]
11. Effects of prostaglandin I2 and forskolin on the secretion from platelets evoked at basal concentrations of cytoplasmic free calcium by thrombin, collagen, phorbol ester and exogenous diacylglycerol.
Rink TJ; Sanchez A
Biochem J; 1984 Sep; 222(3):833-6. PubMed ID: 6091624
[TBL] [Abstract][Full Text] [Related]
12. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
Rao AK; Willis J; Kowalska MA; Wachtfogel YT; Colman RW
Blood; 1988 Feb; 71(2):494-501. PubMed ID: 2827817
[TBL] [Abstract][Full Text] [Related]
13. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
Hamid S; Whittle BJ
Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
[TBL] [Abstract][Full Text] [Related]
14. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
Siegl AM; Daly JW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
[TBL] [Abstract][Full Text] [Related]
15. Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.
Jakobs KH; Bauer S; Watanabe Y
Eur J Biochem; 1985 Sep; 151(2):425-30. PubMed ID: 4040856
[TBL] [Abstract][Full Text] [Related]
16. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
Fujitani B; Wakitani K
Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of prostaglandin-activated platelet adenylate cyclase.
Cooper B; Schafer AI; Puchalsky D; Handin RI
Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction and platelet inhibitory agonists.
Osmani AH; Clare KA; Scrutton MC
Thromb Res; 1983 Sep; 31(5):665-74. PubMed ID: 6359573
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
20. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
